Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors
NCT00207077
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Cetuximab + Erlotinib
Sponsor
Eli Lilly and Company